NCT03771625

Brief Summary

BOLD-fMRI and DTI scans are performed to patients with germ cell tumors in the basal ganglia before and after treatments. The changes of the MRI and muscle strength of patients during treatments are evaluated, and the association between these two are investigated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 11, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

June 1, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

July 29, 2019

Status Verified

December 1, 2018

Enrollment Period

2 years

First QC Date

December 4, 2018

Last Update Submit

July 25, 2019

Conditions

Keywords

fMRIDTIIntracranial Germ cell tumorBasal ganglia

Outcome Measures

Primary Outcomes (2)

  • Changes of brain networks measured by BOLD-fMRI after treatments.

    The brain networks during treatments are compared by functional connectivity.

    The fMRI scans are performed: (1) before treatments in one week, (2) before radiotherapy in one week, (3) after radiotherapy in one week, (4) one year after radiotherapy.

  • Changes of white matter fibers measured by DTI after treatments.

    The white matter fibers damaged by tumor are evaluated by FA and MD value.

    The DTI scans are performed along with the fMRI scans.

Secondary Outcomes (1)

  • Changes of muscle strength after treatments.

    The muscle strength evaluation are performed at the same day before the fMRI scans.

Study Arms (1)

single-group studies

All the patients received chemotherapy and radiotherapy.

Radiation: radiotherapy

Interventions

radiotherapyRADIATION

whole brain with/without spinal cord

Also known as: chemotherapy
single-group studies

Eligibility Criteria

Age3 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with intracranial germ cell tumor located at the basal ganglia.

You may qualify if:

  • age ≥3 years;
  • no history of brain radiotherapy;
  • no other known cause of movement and cognitive impairment;
  • no contraindications to the magnetic resonance imaging (MRI) scan;

You may not qualify if:

  • patients can not tolerate MR scan;
  • head motion is greater than 3 mm during functional MRI scanning.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hospital

Beijing, 100071, China

RECRUITING

Related Publications (1)

  • Liang SY, Yang TF, Chen YW, Liang ML, Chen HH, Chang KP, Shan IK, Chen YS, Wong TT. Neuropsychological functions and quality of life in survived patients with intracranial germ cell tumors after treatment. Neuro Oncol. 2013 Nov;15(11):1543-51. doi: 10.1093/neuonc/not127. Epub 2013 Oct 6.

    PMID: 24101738BACKGROUND

MeSH Terms

Interventions

RadiotherapyDrug Therapy

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

Xiaoguang Qiu, M.D.

CONTACT

Shuai Liu, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2018

First Posted

December 11, 2018

Study Start

June 1, 2019

Primary Completion

June 1, 2021

Study Completion

November 1, 2021

Last Updated

July 29, 2019

Record last verified: 2018-12

Locations